TY  - GEN
AU  - Ozaki,Kei-Ichi
AU  - Awazu,Midori
AU  - Tamiya,Mayuko
AU  - Iwasaki,Yuka
AU  - Harada,Aya
AU  - Kugisaki,Satomi
AU  - Tanimura,Susumu
AU  - Kohno,Michiaki
TI  - Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes
SN  - 1522-1555
PY  - 2017///0612
KW  - 3T3-L1 Cells
KW  - Adipocytes
KW  - drug effects
KW  - Adipokines
KW  - metabolism
KW  - Adiponectin
KW  - Animals
KW  - Benzamides
KW  - pharmacology
KW  - Blood Glucose
KW  - Chemokine CCL2
KW  - Diabetes Mellitus, Type 2
KW  - Diet, High-Fat
KW  - Diphenylamine
KW  - analogs & derivatives
KW  - Disease Models, Animal
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - antagonists & inhibitors
KW  - Fatty Acids, Nonesterified
KW  - Glucose Tolerance Test
KW  - Hyperlipidemias
KW  - Immunoblotting
KW  - In Vitro Techniques
KW  - Insulin
KW  - Insulin Resistance
KW  - Interleukin-6
KW  - Lipolysis
KW  - MAP Kinase Signaling System
KW  - Male
KW  - Mice
KW  - Protein Kinase Inhibitors
KW  - Real-Time Polymerase Chain Reaction
KW  - Receptors, Leptin
KW  - deficiency
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Signal Transduction
KW  - Triglycerides
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1152/ajpendo.00445.2015
ER  -